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The origin of angiomyolipoma and of other tuberous sclerosis associated neoplasms is still 
unknown. Two studies show that they derive from a a multipotent cancer stem cell originated from a 
multipotent renal epithelium, providing a link between stemness and tumourigenesis also in the 
kidney. 
 
Tuberous sclerosis complex (TSC) is a multisystem disorder caused by mutations in one of two 
genes, TSC1 and TSC2, that affects about 1 in 6000 individuals and is characterized by mostly 
benign tumours and other type of lesions that can develop in multiple organs (1). In the kidneys, 
cysts, renal cell carcinomas, and particularly angiomyolipoma (AML) can occur (1). Renal AML 
are benign neoplasms that contain variable admixtures of tumour cells histologically and 
molecularly similar to vascular (angio-), smooth muscle (myo-) and fat (lipo-) lineages (1,2). AMLs 
are observed in the majority of patients with TSC, but can also arise sporadically, affecting ~0.6% 
of females and 0.3% of males in the general population (1,2).  
Genetic analyses have shown that AML are clonal (3), indicating they originate from a single 
tumour-initiating cell with the capacity to differentiate into all these distinct lineages, but the 
mechanisms behind this plasticity are unclear. As embryonic neural crest stem cells or neural crest-
derived progenitor cells from the adult skin can differentiate to form melanocytes, adipocytes, and 
smooth muscle cells, the cell type of origin of renal AML has been proposed to be an unidentified 
kidney-resident cell, neural crest-derived lineage, myoblasts, pericytes or lymphatic endothelium 
(1,4)  
Two studies recently published in Nature Communications show that the source of this plasticity 
resides in the derivation of these tumors from a cancer stem cell (CSC) originating from the renal 
epithelium (5,6) (Figure 1). Indeed, Goncalves et al. showed that TSC2 knockdown transforms 
senescence-resistant cultured mouse and human renal epithelial cells into neoplastic stem cells (SC) 
that serially propagate renal AML-like tumours in mice  (5). In addition, deletion of Tsc1 in mouse 
renal epithelia causes differentiation in vivo into cells expressing characteristic AML markers 
(5). Consistently, Cho et al. showed that hyperactivation of a Rheb-Notch-Rheb regulatory loop is a 
key event to block cell differentiation of the multi-lineage, SC characteristics of AML cells, 
maintaining their multipotency (6) (Figure 1).  
The observation that the multiple cell lineages AML derive from a CSC directly generated from a 
proximal tubular epithelial cell is intriguing and somehow surprising. Indeed, this observation 
suggests that tubular epithelium can potentially display multidifferentiation capacity, going beyond 
the epithelial phenotype that has been considered its only possible option. However, under certain 
circumstances a subset of renal epithelial cells exhibits cellular plasticity and displays progenitor- or 
SC-like properties (7,8) (Figure 1). Indeed, both Goncalves et al. and Cho et al. suggest the 
potential origin for TSC-associated renal cell carcinoma (RCC) from renal epithelial cells localized 
in the Bowman’s capsule urinary pole. Isolation of this population by cell sorting using two markers 
that specifically characterize it, CD133 and CD24, from adult human kidney tissues, revealed that 
these cells can grow as sphere and resist senescence and could be differentiated in culture into 
several types of renal epithelial cells, adipocytes, osteoblasts, endothelial cells and neuronal cells, 
suggestive of a multi-potent progenitor cell phenotype (7,8). In vivo transplantation of clonal 
populations in different mice models of kidney injury showed that these cells can generate 
endothelium as well as different types of tubular epithelimun in acute tubular injury, where mostly 
vascular and tubular cells are damaged, or podocytes and tubular epithelium in adriamycin 
nephropathy, where injury involves podocytes and tubular cells of different segments (7,8). Of note, 
these properties were not shared by any other epithelial cell of the kidney used as controls for in 
vitro and in vivo experiments (7,8). 
Although multipotent progenitors exist in the adult kidney, when lineage tracing techniques are 
applied to renal epithelium, homeostasis and regeneration after acute kidney injury only involves 
unipotent progenitors specific for each tubule segments (9) (Figure 1). This apparent discrepancy is 
not surprising. The behavior of normal adult SC assessed by lineage tracing differs substantially 
from that inferred through cell culture or transplantation experiments (10). Hair-follicle SC give rise 
to all epidermal lineages upon transplantation, but upon lineage tracing generate only hair-follicle 
lineages (10). Similarly, although mammary basal cells are multipotent in transplantation assays, 
these cells are unipotent when interrogated by lineage tracing (10). Overall, these observations 
imply that cell culture experiments and transplantation-based approaches may reveal the potential of 
SC, but the fate of these cells in their own environment in vivo maybe different and largely 
restricted by factors produced by the niche (10). These observations have prompted a revision of the 
classical SC model, that is based on premises and concepts inherited from the canonical hardwired 
SC/CSC hierarchy (10). In this type of cell hierarchy, SC/CSCs are rare, relatively quiescent and 
largely defined by intrinsic properties, such as the capacity to undergo asymmetric division, to 
generate one SC and one more differentiated cells (10). By contrast, organ adult SC can be 
abundant in their niches (e.g. up to 10% of crypt cells are intestinal SC) and a SC division can result 
in zero, one, or two new SC, depending on the available niche space, a process known as neutral 
competition (10). In this perspective, not only genetic alterations, but also signals coming from the 
niche or the microenvironment can modulate plasticity and differentiation capacity of resident adult 
SC, even promoting their transfromation from SC to CSC (10).  
The studies of Goncalves et al. and Cho et al. suggest that signals of the kidney environment in the 
context of TSC1 or -2 gene deletion modulate differentiation of a resident epithelial SC to prime its 
multipotent undifferentiated state and transform it in a CSC that generates AML or RCC (5,6) 
(Figure 1). Intriguingly, Cho et al. also report that cell-specific loss of TSC1 within neuroepithelial-
crest derived precursors, labelled as nestin-expressing cells in adult mice, leads to the formation of 
kidney cysts, renal intraepithelial neoplasia and papillary renal carcinoma, suggesting that other 
TSC-associated tumors may share a similar pathogenesis. 
Although more thorough investigations are required to fully support this notion, these studies 
provide the first direct demonstration of the importance of CSC for the pathogenesis of at least 
some subtypes of renal neoplasms and underline the strict link between stemness and 
tumourigenesis even in the kidney. Several pharmaceutical companies have launched programs 
aimed at eliminating CSC or at modulating their function and plasticity by modulating the tumor 
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Figure 1. Scheme summarizing the link between stemness and tumorigenesis in the kidney  
Renal epithelial cells showing multilineage differentiation potential have been described in the adult 
kidney. After kidney injury these cells can only differentiate into other epithelial cells. However, 
angiomyolipoma, that is clonally generated by multipotent renal epithelial cells, shows multilineage 
differentiation potential not only in cells of the epithelial renal lineage, but also into adipocyte, 
vascular cells, myocytes and neural cells that can all be observed inside this tumor. A Rheb-Notch-
Rheb loop, activated upon TSC1 or -2 gene deletion, controls the undifferentiated “stemness” status 
of angiomyolipoma cells. 
 
AML, angiomyolipoma; TSC, Tuberous Sclerosis Complex. 

